RE:RE:RE:RE:RE:update ...Who wants to wait 3-4 years for possible clinical success nevermind commercial success. The value to QPT shareholders will depend entirely on the SP of OCQ. I would want out as soon as possible. The EGF thing is worth what they paid for it which is nothing. Preclinical asset at best. Not interested thanks. Agreed mgt has done nothing to promote this stock value and story. There was talk of a dividend with anything left after expense which could be 10M which is worth 5-10 cents a share give or take.